Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology-Reference-Cited by-同舟云学术

Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology

Author:

Ji Yan¹,Jin Jin Y.²,Hyman David M.³,Kim Geoffrey⁴,Suri Ajit⁵

Affiliation:

1. PK Sciences; Novartis Institutes for BioMedical Research; East Hanover New Jersey USA

2. Clinical Pharmacology; Genentech Inc.; South San Francisco California USA

3. Early Drug Development Service; Memorial Sloan Kettering Cancer Center; New York New York USA

4. Office of Hematology and Oncology Products (OHOP); U.S. Food and Drug Administration; Silver Spring Maryland USA

5. Quantitative Clinical Pharmacology; Takeda International Inc.; Cambridge Massachusetts USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference47 articles.

1. Cancer immunotherapy;Couzin-Frankel;Science,2013

5. Optimizing dosing of oncology drugs;Minasian;Clin. Pharmacol. Ther,2014

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献